Medical Cannabis for Arthritis: A Complete Patient & Caregiver Resource Guide

Arthritis can affect how you walk, sleep, work, exercise, and handle ordinary tasks with your hands. Medical cannabis may offer symptom support when pain, stiffness, or poor sleep continues despite a treatment plan.  This guide will help you understand whether consulting a medical marijuana doctor is worth it, what cannabis can realistically do, and how to use it with clear goals. You will also learn how to compare products, track results, protect your current treatment, and discuss cannabis safely and confidently with your healthcare team.

1. How to Use This Patient Guide

1.1 What this guide will help patients decide

This guide helps you decide whether medical cannabis fits your diagnosed form of arthritis and the symptom that affects you most. Start by identifying one practical treatment target rather than hoping a single product will improve every aspect of your condition. Your first goal might be:

• Less pain while walking, climbing stairs, cooking, dressing, or working
• Fewer pain-related awakenings during the night
• Greater comfort during exercise, stretching, or physical therapy
• Less distress from persistent aching after activity
• Better tolerance of treatment-related discomfort

You will also learn how to compare THC, CBD, balanced products, topicals, oils, capsules, edibles, and inhaled options. The guide explains how to plan a structured trial, measure meaningful improvement, recognize unacceptable effects, and decide whether the cost and results justify continued use.

1.2 What medical cannabis may and may not do

Medical cannabis may help some patients manage selected symptoms, including pain, sleep disruption, tension, or discomfort that continues alongside standard arthritis care. Your response may depend on your diagnosis, the source of your pain, the cannabinoid content, the dose, the route, your other medicines, and your previous cannabis experience. Cannabis does not cure arthritis, rebuild cartilage, reverse joint damage, remove urate crystals, or reliably control immune-driven inflammation. It should not replace disease-modifying medicines, biologics, urate-lowering therapy, rehabilitation, exercise, joint protection, or surgery when those treatments are medically appropriate. A meaningful benefit should appear in your daily life. Feeling calm, sleepy, or intoxicated is not enough on its own. A useful result may mean that you sleep longer, move more comfortably, complete hand tasks with less difficulty, or participate more consistently in therapy without side effects that interfere with safety or judgment.

1.3 How to interpret the language used in the guide

The wording in this guide reflects the strength of the available evidence. “May help” means that a benefit is possible for some patients but cannot be promised. “Limited evidence” means researchers do not yet have enough strong studies to reach a confident conclusion. “Mixed evidence” means different studies have produced conflicting results. “Not established” means dependable clinical research has not confirmed the claim. You should also separate laboratory findings from results in people. A cannabinoid may affect cells, inflammation pathways, or animals without producing the same outcome in a person with arthritis. Patient-reported relief matters, but it does not prove that swelling, inflammatory markers, disease activity, or structural damage has improved. Use symptom relief as one part of the decision, not as proof that your arthritis is controlled. New swelling, redness, heat, fever, weakness, rapidly worsening pain, or an unexplained change in function still requires medical evaluation.

2. First, Identify Which Type of Arthritis You Have

2.1 Osteoarthritis

Osteoarthritis develops when the tissues within a joint change over time. Cartilage may become thinner, the bone beneath it may change, and the joint may become less able to move smoothly. You may notice aching, stiffness, tenderness, reduced movement, or pain that becomes stronger when you walk, lift, grip, bend, or place weight on the joint. Commonly affected areas include the knees, hips, hands, thumb bases, spine, feet, and shoulders. Morning stiffness is often brief, while pain may increase after activity or after the joint has carried weight for a long period. Symptoms can also become more noticeable during temporary periods of increased irritation. Medical cannabis research involving one osteoarthritic joint should not automatically be applied to every other joint. A topical product studied on the thumb may not produce the same result in a deep hip joint, and an oral product studied for knee pain may not affect hand function in the same way. Your treatment plan should reflect the location, severity, and mechanical cause of your symptoms.

2.2 Inflammatory arthritis

Inflammatory arthritis develops when the immune system causes ongoing inflammation within joints or nearby tissues. This group includes rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, ankylosing spondylitis, reactive arthritis, and arthritis associated with inflammatory bowel disease. You may experience swollen joints, warmth, tenderness, prolonged morning stiffness, fatigue, and symptoms that improve somewhat after you begin moving. Disease activity may rise and fall, so a period of reduced pain does not always mean the inflammation has settled. Some conditions can also affect the skin, eyes, spine, tendons, lungs, or other parts of the body. Cannabis may change how strongly you feel pain, but it has not been established as a treatment that controls immune-driven arthritis. You should continue rheumatology appointments, laboratory monitoring, imaging when needed, and prescribed disease-modifying treatment. Objective monitoring remains important because temporary comfort does not prove that joint damage is being prevented.

2.3 Crystal, infectious, and other arthritis conditions

Not every painful or swollen joint is caused by osteoarthritis or an autoimmune condition. Gout develops when urate crystals collect in and around a joint, while calcium pyrophosphate deposition disease involves a different type of crystal. Arthritis may also follow an injury, occur with lupus, or develop because of an infection. Cannabis does not remove urate crystals, lower uric acid, or treat bacteria inside a joint. Sudden severe pain, heat, redness, swelling, fever, chills, or difficulty using the affected limb requires medical assessment. A joint infection can resemble gout or an inflammatory flare, so reducing the pain without identifying the cause may delay appropriate treatment. You should not assume that every new joint problem is simply another episode of your usual arthritis. Changes in location, intensity, swelling, temperature, or general health may point to a different cause. Accurate diagnosis helps you decide whether cannabis is a reasonable symptom option or whether the joint needs specific medical treatment first.

3. Understanding Medical Cannabis

3.1 Cannabis, marijuana, hemp, and cannabinoid medicines

Cannabis is a plant that contains active compounds called cannabinoids. Marijuana commonly refers to cannabis containing enough THC to produce intoxicating effects, while hemp is legally defined by its lower THC content. Medical cannabis describes cannabis used to manage a health symptom, but the word “medical” does not guarantee that a product has proven effectiveness, consistent strength, or pharmaceutical quality. You may see several product categories:

• Regulated medical cannabis sold through a licensed dispensary
• Adult-use cannabis sold where recreational access is legal
• Hemp-derived CBD products sold online or in stores
• Intoxicating hemp products containing compounds such as delta-8 THC
• Prescription cannabinoid medicines approved for specific medical conditions

These products are not interchangeable. Testing rules, permitted ingredients, THC limits, manufacturing standards, and label accuracy can differ by state and seller. A product purchased legally in one location may not have the same strength or quality as a product with a similar name sold elsewhere.

3.2 THC and CBD

THC is the main cannabinoid responsible for the intoxicating effects of cannabis. It may change pain perception, relaxation, appetite, sleepiness, attention, memory, coordination, and reaction time. Some arthritis patients may find that a small amount reduces discomfort, while others may experience dizziness, anxiety, confusion, or an uncomfortable high. CBD does not generally cause the same intoxicating effect when used alone, but it is still an active substance. It may cause drowsiness, changes in digestion or appetite, or medication interactions. CBD should not automatically be considered harmless simply because it is sold without a medical cannabis card. According to a 2023 advisory from the SAMHSA, delta-9 THC produces psychoactive effects, while pure CBD does not, although CBD may still cause drowsiness, digestive symptoms, and drug interactions.  Products may be described as THC-dominant, CBD-dominant, or balanced. These terms matter less than the actual number of milligrams in each dose. A higher concentration does not automatically produce better arthritis relief, and strain names alone cannot tell you how strongly a product will affect pain, sleep, thinking, or movement.

3.3 Regulatory approval versus medical authorization

FDA approval means that a specific medicine has been reviewed for its ingredients, manufacturing, safety, effectiveness, dose, and intended use. The FDA has not approved the cannabis plant or ordinary dispensary products as treatments for arthritis. Approved cannabinoid medicines are prescribed for specific conditions that are unrelated to most forms of arthritis. State medical cannabis authorization is different. A clinician may certify that you qualify under state law, allowing you to purchase products from a licensed dispensary. This legal access does not prove that every available product has been studied for your diagnosis or that it will improve your symptoms. Separate legality from effectiveness when making decisions. A product may be legally available but poorly studied, while another may contain a cannabinoid that has been studied in a different disease or at a different dose. Your arthritis diagnosis, treatment goal, product label, medication list, and response diary remain more useful than legal availability alone.

4. How Cannabis Might Affect Arthritis Symptoms

4.1 Pain signaling

Cannabinoids may influence how pain signals are processed in the nervous system. This could change how strongly you notice aching, burning, tenderness, or discomfort, even when the structure of the joint remains unchanged. Arthritis pain can come from cartilage and bone changes, inflammation, muscles, tendons, nerves, poor sleep, stress, and previous pain experiences. Reducing pain perception is not the same as correcting the cause of pain. You may feel more comfortable without any changes in swelling, joint space, cartilage loss, uric acid levels, or immune activity. This is why symptom relief should be measured alongside movement, function, and medical monitoring. Biological explanations can help researchers understand possible effects, but they do not prove that a product will work for you. The most useful evidence comes from well-designed studies in patients with the same type of arthritis, joint location, route, dose, and treatment duration.

4.2 Sleep, relaxation, and coping

Pain can make it difficult to fall asleep, stay asleep, or find a comfortable position. Some cannabis products may help you feel more relaxed or less focused on discomfort, which may reduce pain-related awakenings. Better sleep may also make it easier to cope with stiffness, fatigue, and daily activity the following day. Sedation is not always the same as restorative sleep. A product may make you fall asleep quickly but leave you feeling foggy, dizzy, or unsteady the next morning. Track total sleep, awakenings, morning alertness, balance, and your ability to complete normal tasks. A product that helps at bedtime may not be appropriate during the day. THC may reduce tension for some patients but increase anxiety or irritability in others. Your goal should be improved sleep and coping without sacrificing clear thinking, safe movement, or participation in treatment.

4.3 Inflammation claims

Laboratory studies have found that cannabinoids can affect certain inflammatory pathways, but these findings do not establish that cannabis controls arthritis inflammation in people. Effects observed in cells or animals may not appear in patients at realistic doses. Claims that cannabis treats inflammation should therefore be interpreted carefully. Pain relief does not prove that synovitis, inflammatory markers, or disease activity have improved. This distinction is especially important in rheumatoid arthritis, psoriatic arthritis, and other immune-driven conditions. You may feel less pain while inflammation continues to damage joints or nearby tissues. Cannabis should not be described as a disease-modifying antirheumatic drug. Continue prescribed treatment and objective monitoring through your rheumatology plan, including joint examinations, laboratory testing, imaging, and disease activity reviews when appropriate. Cannabis may support symptom management, but it should not quietly replace the treatments used to control the disease itself.

5. What the Arthritis Research Actually Shows

5.1 Osteoarthritis research

Research on cannabis for osteoarthritis has produced mixed results. The findings depend heavily on the affected joint, the cannabinoid, the dose, the product type, the route, and the treatment period. A study involving topical CBD for thumb base arthritis cannot provide a reliable answer about oral CBD for knee pain or THC-containing cannabis for hip arthritis. According to a 2021 clinical practice guideline by Busse et al., noninhaled medical cannabis may provide notable improvements in pain, physical function, and sleep for some patients with chronic pain, but results vary and must be weighed against side effects.  Recent controlled trials of oral CBD have not shown consistent pain relief for knee osteoarthritis, hand osteoarthritis, or arthritis symptoms involving psoriatic disease. In contrast, a small study of topical CBD applied to the base of the thumb reported improvement. This difference shows why all cannabis products should not be placed in a single category. Participants receiving a placebo may also report improvement because symptoms naturally change, expectations affect pain reporting, and regular study contact can influence behavior. Small groups and short treatment periods make it difficult to know whether an apparent benefit would continue during everyday use. You should therefore look for research that closely matches your diagnosis, painful joint, route, and product.

5.2 Rheumatoid and inflammatory arthritis research

Research involving rheumatoid arthritis and other inflammatory conditions remains limited. One small preliminary study of a cannabis based mouth spray reported improvement in certain pain and sleep outcomes. However, the study was not large or long enough to establish cannabis as a dependable treatment for rheumatoid arthritis. Reduced pain or improved sleep does not prove that immune activity has decreased. A study may record how patients feel without showing meaningful changes in swollen joints, inflammatory markers, imaging results, structural damage, or future disability. These outcomes must be considered separately. There is even less dependable research involving psoriatic arthritis, axial spondyloarthritis, and several other inflammatory conditions. Current evidence does not support replacing methotrexate, biologics, or other disease-modifying treatments with cannabis. Cannabis may be discussed as additional symptom support, but your rheumatology plan remains responsible for controlling inflammation and protecting joints.

5.3 How to read cannabis research critically

Begin by checking whether a study was randomized, blinded, and compared with a placebo. These features reduce the chance that expectations, researcher influence, or natural symptom changes will be mistaken for a treatment effect. Observational research can identify patterns, but it cannot prove that cannabis caused the reported improvement. Next, confirm that the participants had the same arthritis diagnosis as you. Results from people with knee osteoarthritis may not apply to rheumatoid arthritis, and findings from thumb pain may not apply to deep hip pain. You should also compare the exact THC and CBD amounts, route, frequency, and treatment duration with the product being considered. Do not focus only on the average pain score. Look for changes in walking, hand use, sleep, exercise, work, treatment withdrawal, and unwanted effects. A result can be statistically significant while remaining too small to improve daily life. Meaningful evidence should help you understand both the possible benefit and the practical cost of achieving it.

6. Choosing the Right Treatment Target

6.1 Identifying the primary symptom

Before trying cannabis, decide which problem you are actually attempting to improve. Arthritis can cause pain, stiffness, swelling, fatigue, sleep disruption, emotional distress, and reduced function. Cannabis may affect some of these experiences differently, so using it without a defined target makes the result difficult to judge. Record the affected joint or body region and the time when the symptom is strongest. Your pattern may involve morning stiffness, nighttime aching, pain after activity, discomfort during a flare, or symptoms that continue throughout the day. Choose one primary target for the initial trial, such as:

• Knee pain during walking
• Hand pain while cooking or dressing
• Hip discomfort that interrupts sleep
• Pain that limits prescribed exercise
• Nighttime aching that causes repeated waking

Unexplained swelling, redness, heat, weakness, fever, or a sudden change from your usual pattern should be medically assessed before you treat it as routine arthritis pain.

6.2 Setting a functional goal

A functional goal describes what you hope to do more comfortably rather than simply asking for a lower pain number. This makes it easier to decide whether cannabis is producing a result that matters in your daily life. Your goal might be to:

• Walk a defined distance with less discomfort
• Climb a flight of stairs more comfortably
• Prepare a meal with fewer hand pain interruptions
• Dress or open containers with less difficulty
• Sleep with fewer pain-related awakenings
• Complete physical therapy or exercise more consistently
• Participate in work or social activities for longer

Choose a goal that you can observe and record. “Feeling better” is difficult to measure, whereas walking for 15 minutes or waking once rather than 4 times provides clearer information. Your goal should also reflect your diagnosis, current ability, and broader treatment plan.

6.3 Defining success before starting

Decide what level of improvement would make continued cannabis use worthwhile. You may require a noticeable reduction in activity pain, fewer sleep interruptions, or easier completion of one important task. A small change may still matter when it improves independence, but mild relaxation alone should not automatically count as success. Define your limits before the first dose:

• The minimum symptom or functional improvement required
• The amount of sleepiness or dizziness you will accept
• Whether any intoxication is acceptable
• Which side effects mean you will reduce or stop
• The maximum monthly amount you can afford
• The date when you will review the results
• The length of the trial before deciding it has failed

Clear rules protect you from continuing to use an ineffective product because you have already spent money or become accustomed to it. Success means the benefit is repeatable, practical, affordable, and achieved without interfering with movement, thinking, prescribed treatment, or daily safety.

7. Medical Cannabis and Osteoarthritis

7.1 What symptoms might reasonably be targeted

Medical cannabis may be considered when osteoarthritis symptoms continue to interfere with movement, sleep, exercise, work, or everyday tasks despite an established care plan. The most appropriate targets are symptoms you can clearly describe and consistently track before and during a trial. Possible treatment targets include:

• Activity-related pain during walking, climbing stairs, lifting, bending, or using your hands
• Persistent aching that continues after movement
• Nighttime discomfort that interrupts sleep
• Pain that limits physical therapy or prescribed exercise
• Distress caused by recurring joint discomfort

A 2021 systematic review by Wang et al. found that noninhaled medical cannabis and cannabinoids produced improvements in pain, physical functioning, and sleep quality among some patients living with chronic pain  Choose one main symptom at first rather than trying to improve everything at once. Record the affected joint, the activity that triggers discomfort, how long the pain lasts, and what you cannot currently do comfortably. This gives you a clear way to decide whether cannabis provides useful symptom relief.

7.2 What cannabis will not address directly

Cannabis may change how strongly you experience osteoarthritis pain, but it does not correct structural or mechanical problems within the joint. It cannot rebuild cartilage, restore lost joint space, straighten a deformity, repair a fracture, or remove loose fragments of bone or cartilage. It also does not directly correct joint instability, muscle weakness, unsuitable footwear, poor walking mechanics, or problems involving braces, canes, and other mobility equipment. These issues may continue to limit movement even when pain temporarily feels less intense. Seek further assessment if a joint repeatedly gives way, locks, changes shape, becomes suddenly swollen, or loses function. Advanced hip or knee damage may still require an orthopedic review or a joint replacement discussion. Cannabis may support comfort while you consider these options, but it cannot replace the examination and imaging needed to understand progressive joint damage.

7.3 How cannabis fits with established OA care

Cannabis should fit alongside treatments that support strength, movement, independence, and long-term joint function. Your care plan may include exercise, physical therapy, weight management when appropriate, topical medicines, oral pain relief, braces, assistive devices, injections, or orthopedic treatment. Consider timing carefully when using cannabis around physical activity. A dose that reduces discomfort might help you take part in therapy or gentle exercise, but too much THC may affect balance, coordination, reaction time, and movement quality. Test a new product or dose in a safe setting before using it near stairs, pools, exercise machines, or outdoor walking routes. Do not treat reduced pain as permission to place excessive strain on the affected joint. Increase activity gradually and follow the plan provided by your clinician or therapist. If pain improves but walking distance, hand strength, balance, or joint stability continues to decline, the underlying problem may need a different treatment rather than a larger cannabis dose.

8. Medical Cannabis and Rheumatoid Arthritis

8.1 Pain relief versus disease control

Rheumatoid arthritis pain can come from active inflammation, previous joint damage, muscle weakness, nerve irritation, poor sleep, or several causes occurring together. Cannabis may reduce how strongly you feel pain or help you sleep, but these changes do not confirm that the immune activity responsible for rheumatoid arthritis is controlled. Inflammation may continue even when you temporarily feel more comfortable. Pay attention to swollen joints, tenderness, the length of morning stiffness, grip strength, fatigue, and changes in walking or hand function. Your clinician may also use examinations, laboratory testing, imaging, and formal disease activity scores. Cannabis has not been established as a replacement for disease-modifying antirheumatic drugs. Ongoing inflammation can gradually damage joints and reduce function even when pain becomes less noticeable. You can seek added symptom relief while continuing the treatment intended to slow disease activity and protect your joints.

8.2 Cannabis alongside DMARDs and biologics

Continue methotrexate, hydroxychloroquine, sulfasalazine, leflunomide, biologics, or targeted medicines as prescribed unless your rheumatologist changes the plan. These medicines are used to control inflammation and reduce the risk of joint damage, while cannabis is generally considered an additional option for selected symptoms. Tell your rheumatologist and pharmacist which product you intend to use. Share the THC and CBD amounts, route, dose, and frequency, along with your complete medication list. Research on interactions remains incomplete, but liver effects, medication metabolism, dizziness, sleepiness, and reduced alertness may need closer attention. According to a 2023 statement from the U.S. Food and Drug Administration, CBD may harm the liver and interact with certain medications, reinforcing the importance of reviewing cannabis alongside prescribed arthritis treatments.  Do not reduce or stop rheumatoid arthritis medicine because cannabis makes you feel better for several days. Temporary comfort does not show whether the disease has become less active. Continue scheduled monitoring and report new symptoms rather than assuming every change is a cannabis effect.

8.3 Recognizing an RA flare

A rheumatoid arthritis flare may involve increased swelling, tenderness, stiffness, fatigue, or reduced function across several joints. You may notice that morning stiffness lasts longer, gripping becomes harder, walking becomes more uncomfortable, or symptoms begin affecting joints that were previously stable. Pain is not the only sign of a flare. Increased fatigue, reduced hand strength, fever, general illness, or a clear change from your usual pattern may also require attention. Cannabis could make the pain feel less severe while the inflammation continues. Contact your rheumatology team when symptoms worsen, last longer than your usual pattern, or significantly interfere with movement and daily care. Do not respond to a possible flare-up only by taking more THC or using cannabis more often. Your clinician may need to assess inflammation, infection risk, medication adherence, laboratory results, or the effectiveness of your current rheumatoid arthritis treatment.

9. Medical Cannabis and Psoriatic Arthritis

9.1 Joint, tendon, spine, and skin symptoms

Psoriatic arthritis can affect more than the joints in your hands, knees, or feet. It may cause pain where tendons and ligaments attach to bone, known as enthesitis, or make an entire finger or toe swell, known as dactylitis. Some patients also have spinal stiffness, psoriasis plaques, scalp symptoms, or nail changes. Before using cannabis, identify the exact symptom you want to address. A product might help you sleep through joint discomfort without changing your skin plaques, nail disease, tendon pain, or spinal stiffness. Feeling better in one area does not mean every part of psoriatic arthritis has improved. Track joint and skin symptoms separately. Record swelling, morning stiffness, tendon tenderness, swollen fingers or toes, spinal mobility, nail changes, and psoriasis activity alongside pain and sleep. This fuller record helps you and your healthcare team see whether cannabis is supporting comfort while other signs of disease remain active.

9.2 Protecting disease-modifying treatment

Psoriatic arthritis may require conventional disease-modifying medicines, biologics, or targeted treatments to control inflammation and protect joints, tendons, and the spine. Cannabis has not been established as a replacement for these therapies, even when it temporarily reduces pain or helps you rest. Reduced discomfort does not confirm that enthesitis, dactylitis, spinal inflammation, or joint swelling is controlled. Do not stop or reduce prescribed treatment after a brief period of feeling better. Continue rheumatology monitoring, laboratory testing, skin examinations, and other follow-up recommended by your clinicians. Tell your care team about the THC and CBD products you use, especially when you take medicines that affect the immune system or liver. Report fever, infection symptoms, unusual fatigue, or changes in laboratory results. Coordination between rheumatology and dermatology may be useful when joint and skin symptoms respond differently.

9.3 Interpreting the limited evidence

Research specifically studying cannabis for psoriatic arthritis remains limited. A controlled study that included people with hand osteoarthritis and psoriatic arthritis did not find meaningful pain improvement from CBD compared with placebo. This does not prove that every cannabis product will fail, but it prevents strong claims about dependable benefit. Evidence involving CBD creams for psoriasis should not be automatically applied to inflammation inside joints, tendons, or the spine. Topical skin products, oral CBD, THC-containing products, and balanced products enter the body differently and cannot be treated as equivalent. There is also no strong, product-specific dosing standard for psoriatic arthritis. Personal testimonials can describe individual experiences, but they cannot show whether inflammation is controlled or future damage is being prevented. Cannabis is best considered optional symptom support within a complete treatment plan rather than a central treatment for the disease.

10. Medical Cannabis and Gout or Crystal Arthritis

10.1 Acute gout attacks

An acute gout attack can cause severe pain, redness, heat, tenderness, and rapid swelling, often in the big toe, ankle, or knee. These symptoms require appropriate assessment because an infected joint can resemble gout and may require urgent treatment. Cannabis does not remove urate crystals or end the biological process causing the attack. With approval from your treating clinician, it may be considered only as additional support for discomfort while you receive established flare treatment. A 2020 American College of Rheumatology guideline by FitzGerald et al. recommends that colchicine, nonsteroidal anti-inflammatory drugs, or glucocorticoids be first-line treatments for gout flares, so cannabis should remain additional symptom support rather than replace established flare care.  Seek prompt medical care when a swollen joint occurs with:

• Fever, chills, weakness, or a general feeling of illness
• Recent surgery, an injection, a wound, or an infection
• Severe pain that differs from your usual gout pattern
• Inability to move or place weight on the affected joint
• Immune-suppressing treatment or another condition that raises infection risk

Do not allow temporary pain relief from cannabis to delay testing when infection cannot be ruled out. A joint infection requires medical treatment rather than symptom management alone.

10.2 Long-term uric acid management

Long-term gout care focuses on lowering and maintaining uric acid levels to reduce crystal formation. Medicines such as allopurinol may be prescribed to prevent future attacks, reduce tophi, and slow ongoing crystal buildup. Cannabis does not perform this role. Feeling less pain does not mean your uric acid level has reached its treatment target. Continue monitoring serum urate and attack frequency, tophi, kidney health, and medication adherence with your clinician. Do not stop urate-lowering medicine because cannabis makes an attack or persistent joint discomfort easier to tolerate. Alcohol intake, hydration, diet, body weight, kidney function, and certain medicines may also influence gout. These factors should be addressed separately rather than assuming cannabis will offset them. A successful plan combines symptom support with treatment that directly addresses crystal formation.

10.3 CPPD and other crystal conditions

Calcium pyrophosphate deposition disease, commonly called CPPD, involves calcium crystals rather than the urate crystals responsible for gout. It can cause sudden swelling that resembles gout or longer-lasting pain and stiffness that resembles osteoarthritis. Accurate diagnosis may require joint fluid testing, imaging, and clinical evaluation. Cannabis should not be described as a proven anti-inflammatory treatment for CPPD or other crystal conditions. It may alter discomfort for some patients, but it does not remove the crystals or establish why a joint has become swollen. Clinician-directed treatment may include colchicine, anti-inflammatory medicines, corticosteroid injections, or management of associated health conditions. Recurrent attacks deserve proper assessment instead of repeated cannabis experimentation. Knowing which crystal condition you have allows you to combine appropriate medical treatment with cautious symptom support.

11. Understanding the Different Types of Arthritis Pain

11.1 Nociceptive and mechanical pain

Nociceptive and mechanical pain often develops when a joint, muscle, tendon, ligament, or nearby tissue responds to pressure, movement, loading, or structural change. You may feel aching, stiffness, tenderness, or deep soreness that worsens when you walk, climb stairs, grip objects, stand for long periods, or move the affected joint. This type of pain can also come from weak muscles or altered movement patterns. For example, knee arthritis may change how you walk, placing extra strain on the hip, ankle, or lower back. Pain may therefore continue even when inflammation is mild or reasonably controlled. Cannabis may reduce your perception of discomfort, but mechanical problems often need mechanical solutions. Exercise, physical therapy, braces, supportive footwear, assistive devices, joint protection, and changes in movement technique may provide benefits that cannabis cannot. Your strongest plan may combine symptom relief with treatment that improves strength, stability, and movement quality.

11.2 Inflammatory pain

Inflammatory pain is associated with active irritation caused by the immune system or another inflammatory process. You may notice prolonged morning stiffness, warmth, swelling, tenderness, pain after rest, or discomfort that wakes you during the night. Symptoms may improve somewhat after gentle movement, although the joint can remain painful and swollen. This pattern commonly appears in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and related conditions. Inflammation may also cause fatigue, reduced appetite, fever, eye symptoms, skin changes, or a general feeling of being unwell. Cannabis may make inflammatory pain feel less intense, but it does not reliably show whether inflammation has decreased. Continue monitoring swelling, stiffness duration, function, laboratory results, and clinician-assessed disease activity. The main inflammatory disease still requires appropriate treatment, even when cannabis helps you sleep or cope with discomfort.

11.3 Neuropathic and centralized pain

Neuropathic pain comes from irritated, compressed, or damaged nerves rather than only from the joint itself. It may feel burning, electric, shooting, tingling, numb, or unusually sensitive to light touch. Possible causes include nerve compression, diabetic neuropathy, radiculopathy, or nerve pain that continues after surgery. Centralized pain occurs when the nervous system becomes unusually sensitive and amplifies pain signals. You may experience widespread discomfort, fatigue, poor sleep, difficulty concentrating, or overlapping fibromyalgia. The intensity of pain may seem greater than expected from the visible joint changes. Neuropathic and centralized pain can respond differently from ordinary joint aching, so identifying the pain type matters before choosing a cannabis product. Do not assume every burning or widespread symptom comes directly from arthritis. A clinician may need to assess nerve function, spinal problems, diabetes, fibromyalgia, medication effects, and other causes before you begin or adjust cannabis.

12. Arthritis Symptoms That Should Not Be Self-Treated With Cannabis

12.1 A hot, red, suddenly swollen joint

A joint that becomes hot, red, severely painful, or swollen over a short period needs proper medical evaluation. Possible causes include gout, calcium crystal disease, infection, injury, or an inflammatory arthritis flare. These conditions can look similar at home but may require very different treatment. Fever, chills, weakness, recent surgery, a joint injection, an open wound, or a recent infection make prompt assessment especially important. The risk may also be higher when you use biologics, corticosteroids, or other medicines that suppress immune activity. Seek same-day or urgent care when infection is possible. Cannabis might make the pain feel less severe, but it cannot determine the cause or treat bacteria inside a joint. Reducing discomfort must not delay joint fluid testing, imaging, antibiotics, or any other treatment your clinician deems necessary.

12.2 New neurological or vascular symptoms

New nerve or circulation symptoms should not be managed by simply increasing cannabis. These changes may point to pressure on the spinal cord or nerves, interrupted blood flow, a clot, or another problem that requires urgent care. Get immediate medical help for:

• New weakness or inability to move or use a limb
• Sudden loss of sensation or rapidly spreading numbness
• A cold, pale, blue, or unusually dark hand, foot, arm, or leg
• Severe swelling with a weak or absent pulse
• New loss of bowel or bladder control with back pain
• Numbness around the groin or inner thighs
• Severe neck or back pain accompanied by weakness or loss of coordination

Do not drive yourself after using an intoxicating product. Tell the emergency team what you took, how much you used, and when you used it. This information helps clinicians separate cannabis effects from the medical symptoms being assessed.

12.3 Unexplained systemic change

Arthritis can affect your general health, but new symptoms involving the whole body deserve attention rather than automatic self-treatment. Unintentional weight loss, persistent fever, night sweats, repeated vomiting, severe abdominal symptoms, chest pain, or shortness of breath may have causes that cannabis cannot address. You should also seek assessment when new pain begins after a fall, injury, or medication change. Cannabis may reduce pain awareness while a fracture, internal injury, medication reaction, or serious illness remains untreated. This concern is especially important when osteoporosis, blood-thinning medication, immunosuppression, or frequent falls increase your risk. Report how the symptom began, what makes it worse, and whether it differs from your usual arthritis pattern. Cannabis can remain part of your symptom plan after dangerous causes have been excluded, but it should not be used to avoid or postpone an examination when your overall health has clearly changed.

13. THC, CBD, Ratios, and Marketing Terminology

13.1 Understanding THC

THC is the main cannabinoid responsible for cannabis intoxication. It may change pain perception, promote relaxation, increase appetite, or make you sleepy. It can also slow thinking, affect short-term memory, reduce coordination, and cause dizziness, anxiety, paranoia, or an uncomfortable sense of losing control. More THC does not necessarily produce greater arthritis relief. A larger dose may increase impairment without improving walking, sleep, hand use, or exercise tolerance. The most useful amount is the lowest dose that supports your defined goal without causing adverse effects that compromise daily safety. According to 2021 consensus recommendations by Bhaskar et al., higher oral THC doses were more likely to impair cognitive and psychomotor performance and cause unpleasant effects, supporting slow titration toward the lowest dose that meets your treatment goal.  Your sensitivity may depend on your age, health, previous cannabis experience, and frequency of use. A person who uses THC regularly may tolerate an amount that causes strong effects in a new user. Older adults and cannabis naive patients may be especially sensitive to dizziness, confusion, blood pressure changes, and balance problems.

13.2 Understanding CBD

CBD does not usually produce the THC-like high associated with cannabis, but that does not make it inactive or automatically safe. It may cause sleepiness, diarrhea, changes in appetite, nausea, or other digestive symptoms. CBD can also affect how your body processes certain prescription medicines. Liver concerns may be especially relevant when CBD is combined with medicines that already require liver monitoring. Patients taking multiple prescriptions should ask a pharmacist or clinician to review potential interactions before starting regular use. CBD sold over the counter has not been proven to treat arthritis. Product strength and purity may differ from the label, and some items may contain unexpected THC. This could cause intoxication or a positive drug test. Choose regulated products with clear batch testing when available, and record the exact CBD and THC amounts rather than assuming a product is safe because the package says natural.

13.3 Ratios, minor cannabinoids, and terpenes

A ratio describes the relationship between CBD and THC, but you still need to know the actual milligrams of each cannabinoid. A balanced product containing one milligram of each cannabinoid is very different from one containing twenty milligrams of each. Common product descriptions include:

• CBD-dominant products with much more CBD than THC
• Balanced products containing similar amounts of CBD and THC
• THC-dominant products with much more THC than CBD
• Products containing minor cannabinoids such as CBG, CBN, or THCV
• Products promoted according to terpene content or strain category

Minor cannabinoids have not been studied well enough to support dependable arthritis claims. Labels such as indica and sativa also do not reliably predict whether a product will improve pain, sleep, energy, or relaxation. Terpenes may affect aroma and flavor, but marketing claims about specific arthritis benefits often extend beyond established clinical evidence.

14. Comparing Routes of Administration

14.1 Oral oils, capsules, and edibles

Oral products include oils that are swallowed, capsules, tablets, gummies, chocolates, drinks, and other edibles. Their effects usually begin more slowly than inhaled cannabis because the product must pass through digestion and liver processing. Effects may also last longer, which can be useful for nighttime symptoms but difficult if the dose feels too strong. The delayed onset creates a risk of taking another dose too soon. You may assume the first amount failed and take more before the full effect appears. This can lead to prolonged intoxication, dizziness, anxiety, or poor coordination. Read the label carefully to identify milligrams per capsule, gummy, milliliter, or serving. Also, check the total amount in the package, as one container may contain several doses. Record whether you take the product with food, since meals may change the timing or strength of the effect. Consider sugar content, swallowing difficulty, and digestive sensitivity when selecting an oral option.

14.2 Inhaled cannabis

Inhaled cannabis usually begins working faster than oral cannabis and often has a shorter duration. This quicker response may make it easier to notice how a small amount affects pain, but rapid onset does not make inhalation the safest route. Smoking exposes the lungs to combustion products. Dry herb vaporization heats cannabis without burning it, while cartridges heat concentrated oils that may contain additional ingredients. Concentrates can deliver large amounts of THC quickly and may be difficult for a new or sensitive patient to dose accurately. Patients with lung disease, heart disease, circulation problems, or significant breathing symptoms should discuss inhalation with a clinician. Coughing, chest discomfort, dizziness, and a rapid heart rate may occur. Avoid high-potency concentrates when you are inexperienced with THC. Never assume that one puff represents a standard dose, as device strength, inhalation depth, and product concentration vary.

14.3 Oromucosal and other systemic products

Oromucosal products include sprays, tinctures, drops, and lozenges that are placed under the tongue or against the inside of the cheek. Some cannabinoids may be absorbed through the mouth, while the portion you swallow may act more like an edible and produce a later second phase of effects. These products can provide more dose flexibility than a fixed capsule or gummy when the label clearly states the amount per spray, drop, or milliliter. Use a measured dropper or syringe rather than estimating part of a dropper. Check the instructions for how long to hold the product in your mouth and whether eating or drinking should be delayed afterward. Some tinctures contain alcohol and may cause burning, dryness, or mouth irritation. Convenience and portability may be useful, but onset and duration still vary. Follow the directions for the specific product rather than assuming every tincture or spray works the same way.

15. Topical Cannabis Products for Arthritic Joints

15.1 What “topical” actually means

Topical cannabis products include creams, lotions, balms, gels, salves, and roll-on products placed directly on the skin. Most ordinary topicals are intended to act near the application site and are not designed to produce strong effects throughout your body. Transdermal patches and certain specially formulated gels differ in that they may deliver cannabinoids into the bloodstream. A product applied over a joint does not necessarily reach the deepest painful tissue. This matters for hips, spinal joints, and other structures located beneath layers of skin, fat, and muscle. A cream that feels helpful on a thumb joint may not produce the same result when applied over a deep hip joint. Read the full ingredient list before deciding that CBD or THC caused the effect. Menthol, camphor, capsaicin, eucalyptus, and essential oils can create cooling, warming, tingling, or numbing sensations. These ingredients may provide temporary comfort even when the cannabinoids contribute little.

15.2 What the evidence suggests

Research on topical cannabinoids for arthritis is still limited. One small controlled trial involving thumb base arthritis found that a topical CBD formulation improved certain pain and disability measures. This result is encouraging, but one small study cannot prove that every CBD cream works for every arthritic joint. A 2022 randomized controlled trial by Heineman et al. found that a specific topical CBD formulation improved pain and disability in patients with thumb basal joint arthritis, although the small study does not establish that retail CBD creams will produce the same results.  Other early studies have mainly examined feasibility, tolerability, or small groups of patients. Large trials confirming which formulation, concentration, dose, and application schedule work best have not yet established dependable guidance. Products sold in dispensaries and stores may also differ considerably from those used in research. Pay attention to the specific study product rather than the word "CBD" alone. Researchers may use a specific concentration, amount, frequency, carrier, and treatment period. You should not assume that a lower-strength retail balm will reproduce the same outcome. Findings involving the hands should also not be treated as proof that topicals relieve pain in the hips, spine, or other deep joints.

15.3 Safe topical use

Examine your skin before applying a new topical product. When appropriate, test a small amount on a limited area and wait to see whether redness, burning, itching, swelling, or a rash develops. Stop using the product if irritation becomes significant or continues after washing the area. Avoid applying cannabis topicals to broken, infected, severely irritated, or recently operated skin unless your clinician has approved it. Keep the product away from your eyes, mouth, genital area, and other sensitive tissues. Wash your hands after use unless your hands are the treatment site. Check the label for warming or cooling ingredients before combining the product with a heating pad, tight brace, compression garment, or hot bath. Heat and covered skin may increase irritation or change absorption. Store the container securely, especially when it resembles ordinary lotion or contains enough THC to create a risk for children or pets.

16. Selecting a Reliable Product

16.1 Reading the cannabis label

Begin with the amount of THC and CBD in one dose rather than relying on the package name or strain. For an oil, check the milligrams in each milliliter. For capsules, gummies, sprays, and other products, identify the amount per unit or per application. Compare the serving size printed on the label with the amount you actually intend to take. One gummy may contain several servings, while one full dropper may contain much more THC than a cautious starting amount. Also, check the total cannabinoid amount in the entire package so you do not confuse package strength with dose strength. Review carrier oils, sweeteners, flavorings, allergens, added medicines, and other active ingredients. Look for the manufacturing date, expiration date, storage directions, and batch number. Clear labels make it easier to measure doses accurately, compare products, report unwanted effects, and purchase the same formulation again when it works reliably.

16.2 Reviewing laboratory testing

A certificate of analysis is a laboratory report describing what was detected in a particular product batch. Match the batch number on the certificate with the number printed on your container. A report from another batch may not accurately describe the product you purchased. Check whether the measured THC and CBD amounts are reasonably close to the label claims. The report may also include testing for pesticides, residual solvents, heavy metals, bacteria, mold, and fungal toxins. Testing requirements differ between jurisdictions, so confirm which categories were actually assessed rather than assuming the product passed every possible safety check. A certificate does not prove that a product treats arthritis. It only provides information about composition and selected contaminants. When legally available, regulated products with accessible batch testing are generally easier to evaluate than products with unclear origins, missing labels, or unverifiable laboratory reports.

16.3 Products to avoid or approach cautiously

Marketing claims should not replace evidence, accurate labeling, or professional advice. Be cautious when a seller promises that one product can rebuild cartilage, cure arthritis, eliminate inflammation permanently, or replace prescribed treatment. Products that deserve particular caution include:

• Homemade edibles or oils with unknown cannabinoid strength
• Products without a complete ingredient list or dose information
• Packages with no batch number or verifiable laboratory report
• Synthetic cannabinoids sold under names such as K2 or Spice
• Intoxicating hemp products with unclear composition
• High-potency concentrates that make small doses difficult to measure
• Products promoted as substitutes for rheumatology care or arthritis medicine

Do not assume that a high price, an attractive package, a celebrity endorsement, or a natural label confirms quality. Select products according to measurable THC and CBD content, testing, ingredients, route, and suitability for your treatment goal. A reliable product should allow you to reproduce a dose without guessing and identify exactly what you used if a side effect occurs.

17. Is Medical Cannabis Appropriate for Me?

17.1 Review your arthritis history

Begin by confirming the exact type of arthritis you have rather than treating every painful joint as the same problem. Record which joints are affected, when symptoms began, whether your condition is inflammatory or structural, and whether examinations or imaging have found active inflammation, cartilage loss, deformity, nerve involvement, or other damage. Review the treatments you have already tried and what happened with each one. Include prescription medicines, topical pain relievers, injections, physical therapy, exercise, braces, weight management, surgery, and previous cannabis use. Note whether a treatment failed completely, produced partial relief, caused side effects, or became difficult to continue because of cost or inconvenience. Choose a specific reason for considering cannabis. Your target may be pain during movement, nighttime discomfort, stiffness, sleep disruption, or difficulty completing an important task. Cannabis is easier to assess when you have one defined goal rather than a general hope that it will make your arthritis better.

17.2 Review health conditions requiring extra caution

Some health conditions can increase the chance of unwanted cannabis effects or make a cautious starting plan especially important. This does not always mean cannabis is unsuitable, but it means your clinician and pharmacist need enough information to help you assess the risks. Discuss cannabis before use if you have:

• Heart disease, irregular heart rhythms, low blood pressure, or a history of fainting
• Liver disease, abnormal liver tests, or medicines requiring liver monitoring
• Kidney disease or reduced kidney function
• Lung disease, breathing problems, or sleep apnea
• Severe anxiety, psychosis, bipolar disorder, or a substance use disorder
• Memory problems, cognitive impairment, poor balance, or frequent falls
• A previous severe or unexpected reaction to THC or another cannabis product

Your age, medication list, and sensitivity to sedation also matter. Older adults may be more affected by confusion, dizziness, blood pressure changes, and delayed reactions. A personal or family history of serious mental health symptoms should be discussed openly because THC may worsen certain experiences.

17.3 Review your daily responsibilities

Consider how cannabis could affect the tasks you perform every day. Driving, commuting, operating machinery, climbing ladders, working at heights, using sharp tools, or holding a public safety role may be incompatible with intoxication or slowed reaction time. Think about your home environment as well. Arthritis may already make stairs, bathing, cooking, dressing, and nighttime bathroom trips difficult. Adding dizziness or poor coordination could increase the risk of falls or burns, particularly if you live alone or use a cane, walker, or other mobility device. You also need to measure and remember doses accurately. Confusing milligrams with milliliters, taking a second edible too soon, or forgetting that a dose was already taken can cause excessive effects. Childcare responsibilities require secure storage and a reliable plan that prevents children from accessing products that resemble sweets, drinks, or ordinary medicine.

18. Talking With Your Rheumatologist and Healthcare Team

18.1 What to tell the clinician

Tell your clinician the exact product you are considering rather than saying only that you plan to try CBD or marijuana. Bring the package or a clear photograph of the label when possible. Share the THC and CBD amounts, route, proposed dose, frequency, ingredient list, and whether the product comes from a regulated source. Describe any previous cannabis experience, including products that helped, failed, or caused unpleasant effects. Your response years ago may not predict your response now, especially when your health, medications, age, or tolerance have changed. Provide a complete list of prescription medicines, nonprescription medicines, supplements, alcohol use, nicotine use, and other substances. Explain the specific arthritis symptom you want to target and the functional result you hope to achieve. This allows the discussion to focus on a measurable treatment goal rather than general approval or disapproval of cannabis.

18.2 What to ask

Ask whether your current pain appears to come from active inflammation, structural joint damage, muscle weakness, nerve irritation, centralized pain, or another cause. Cannabis may affect these pain types differently, and some causes require treatment that cannot be replaced by symptom relief. Ask whether THC or CBD could interact with your current medicines or add to sleepiness, dizziness, bleeding risk, liver strain, or cognitive effects. Determine whether liver tests or other laboratory monitoring should be performed before or during the trial. You should also ask which effects require dose reduction, immediate stopping, or urgent care. Discuss whether pain relief could make a disease flare or worsening damage harder to recognize. Agree on when the trial will be reviewed, which outcomes will be measured, and what result would justify continuing, adjusting, or stopping the product.

18.3 Which professionals may need to be involved

Your rheumatologist can help separate symptom relief from control of inflammatory disease. A primary care clinician may review general health risks, blood pressure, mental health, sleep, and other conditions that influence cannabis safety. A pharmacist can examine your full medication list and identify possible interactions, duplicate sedating effects, or liver concerns. A pain specialist may help when arthritis pain includes nerve symptoms, centralized pain, opioid use, or several overlapping causes. Physical and occupational therapists can assess whether reduced pain improves movement or causes you to exceed safe limits. They can also help with strength, joint protection, braces, mobility equipment, hand tasks, and home safety. An orthopedic surgeon may need to remain involved when severe structural damage, instability, deformity, locking, or continuing loss of function suggests that symptom support alone is no longer enough.

19. Cannabis and Arthritis Medication Interactions

19.1 DMARDs, biologics, and targeted medicines

Arthritis patients may take methotrexate, leflunomide, hydroxychloroquine, sulfasalazine, biologics, or JAK inhibitors to control inflammatory disease. These medicines serve a different purpose from cannabis. They are intended to reduce disease activity and protect joints, while cannabis may be considered for selected symptoms such as pain or disrupted sleep. Research has not examined every cannabis product in combination with every arthritis medicine. The absence of a documented interaction does not prove that a combination is safe. CBD and THC may affect medication processing, and some arthritis treatments already require liver tests, blood counts, or other monitoring. Ask your pharmacist or prescriber to review the exact product before combining it with treatment. Provide the THC and CBD content, route, dose, and planned frequency. Continue watching for signs of infection, unusual fatigue, digestive changes, yellowing of the skin or eyes, or changes in laboratory results. Do not assume that a natural product cannot interact with medicine that alters immune activity.

19.2 Pain, sleep, and muscle-relaxing medicines

Many arthritis patients also use NSAIDs, acetaminophen, opioids, gabapentin, pregabalin, duloxetine, antidepressants, sleep medicines, benzodiazepines, or muscle relaxants. Cannabis does not automatically make every combination prohibited, but using several substances that affect alertness can increase the chance of unwanted effects. THC may contribute to sleepiness, dizziness, slowed reaction time, confusion, and poor coordination. These effects may be stronger when cannabis is combined with opioids, sleep medicines, gabapentin, pregabalin, benzodiazepines, or muscle relaxants. This is especially important when arthritis already affects walking, grip, balance, or the ability to rise from a chair. Do not reduce prescription pain medicine without discussing it with the clinician managing your treatment. A cannabis trial should not involve changing several medicines at once because you may not know which change caused improvement or harm. Seek professional guidance when you feel excessively sleepy, confused, unsteady, or unable to manage your doses safely.

19.3 Other medicines common in arthritis patients

Your interaction review should include medications used for conditions other than arthritis. Blood thinners, blood pressure medicines, diabetes treatments, antiseizure medicines, corticosteroids, antidepressants, antipsychotics, and medicines processed through the liver may require additional attention. CBD can change how certain medicines are processed, while other medicines may change how much CBD remains in your body. The effect depends on the product, dose, frequency, health conditions, and complete medication combination. A low dose used occasionally may not create the same concern as a concentrated product taken every day. Bring an updated medication list to your clinician or pharmacist. Include prescription drugs, nonprescription medicines, vitamins, supplements, alcohol, nicotine, and all cannabis products. A complete review is especially important when you take several prescriptions, have liver or kidney disease, or receive care from several clinicians who may not share the same medication record.

20. Designing a Safe Personal Cannabis Trial

20.1 Establish a baseline

A baseline records how you feel and function before cannabis is introduced. Without it, normal changes in arthritis symptoms may be mistaken for a treatment effect. Record information for several typical days, including both easier and more difficult ones, when possible. Measure pain at rest and during a specific activity. Record how long morning stiffness lasts, whether joints appear swollen, and how your symptoms affect walking, hand use, work, exercise, and sleep. If you have inflammatory arthritis, continue to track disease activity using the measures recommended by your rheumatology team. Include fatigue, mood, concentration, sleep quality, current medicines, and rescue treatments. Avoid beginning cannabis during the same period that you start another medicine, receive an injection, or make a major exercise change unless medically necessary. Changing one part of the plan at a time gives you clearer information about what helped.

20.2 Select one product and one main goal

Begin with one clearly labeled product and one route. Mixing several brands, cannabinoid ratios, topicals, edibles, and inhaled products during the first trial makes it difficult to connect a result or side effect to a specific dose. Choose one primary outcome, such as fewer nighttime awakenings, less knee pain while walking, or easier completion of hand tasks. You may select no more than two secondary outcomes, but your decision should remain centered on the primary goal. Relaxation or intoxication should not replace the functional result you originally wanted. Set a maximum acceptable level of impairment before starting. You may decide that mild sleepiness at bedtime is acceptable, but morning confusion, poor balance, or difficulty managing medicines is not. Record the exact THC and CBD amounts in milligrams, the time of use, when effects begin, how long they last, and whether your main goal improves.

20.3 Set a review and stopping plan

Decide in advance when you will assess tolerability and when you will evaluate effectiveness. The first review should focus on whether the product causes dizziness, anxiety, digestive symptoms, poor coordination, excessive sleepiness, or another effect that makes continued use unsafe. Your plan should define:

• The improvement required to justify continued use
• The maximum level of intoxication or sleepiness you will accept
• The side effects that will prompt a lower dose
• The symptoms that will require complete discontinuation
• The date when function, sleep, pain, and cost will be reviewed
• The circumstances that require contact with your clinician

Do not continue indefinitely because the product occasionally makes you feel calmer. Continued use should produce a repeatable improvement in the selected symptom or activity without interfering with arthritis treatment, movement, thinking, or safety. Stop and seek advice when side effects outweigh benefit, the dose keeps increasing, or cannabis begins delaying assessment of worsening symptoms.

21. Starting Dose, Titration, and Timing

21.1 Start low and change slowly

Begin with the lowest practical amount, especially when the product contains THC. Your response can depend on age, previous cannabis use, body composition, medications, health conditions, and sensitivity to dizziness or sedation. Another patient’s effective dose may be uncomfortable or unsafe for you. Take your first dose in a familiar place where you can sit or lie down safely. Avoid starting before driving, working, exercising, cooking, bathing, climbing stairs, or leaving home alone. Having a trusted adult nearby may be helpful when you have never used THC or have previously experienced strong effects. Change only one part of your plan at a time. Keep the product, route, and timing consistent while slowly adjusting the amount. This approach helps you identify the lowest dose that supports your arthritis goal without causing intoxication, poor balance, confusion, or excessive sleepiness.

21.2 Avoid accidental overconsumption

Different routes require different waiting periods. Inhaled cannabis generally acts sooner, while swallowed oils, capsules, and edibles may take much longer to reach their full effect. Taking another edible because nothing happened immediately can lead to a stronger and longer experience than you intended. Measure oils with a marked syringe or another accurate device. Record the dose in milligrams of THC and CBD rather than writing “one dropper,” “one gummy,” or “a small amount.” Droppers, gummies, and serving sizes can contain very different quantities. Avoid combining several cannabis products on the same day until you understand how each one affects you. If you take too much, stay in a calm, safe place, avoid driving, and ask someone you trust to stay with you. Contact a poison control service or medical professional when you are unsure what to do, and seek urgent help for severe symptoms.

21.3 Time treatment around arthritis activities

Match the timing of cannabis to the symptom and activity you want to improve. Morning use may affect driving or work, while a dose before physical therapy may change balance, reaction time, effort, or awareness of joint strain. Evening use may support sleep but still cause grogginess or poor coordination the following morning. Consider nighttime bathroom trips if arthritis already makes standing and walking difficult. A product that causes dizziness may increase your risk of falls when you get out of bed in low light. Use clear pathways, supportive footwear, mobility equipment, and adequate lighting when needed. Track when relief begins, how long it lasts, and whether pain returns strongly as the effect fades. Record whether cannabis helps you exercise, complete therapy, or sleep more consistently. If it repeatedly reduces participation, causes delayed morning function, or makes movement less safe, the timing, dose, route, or product may need to change.

22. Side Effects and What to Do About Them

22.1 Common dose-related effects

Cannabis effects often become stronger as the THC dose increases. Common experiences include dry mouth, sleepiness, dizziness, altered perception, increased appetite, slowed thinking, reduced concentration, anxiety, and uncomfortable intoxication. CBD may also cause fatigue, diarrhea, nausea, appetite changes, or medication interactions. Mild effects may improve when you lower the dose, use the product less often, or change the time of use. Sit or lie down if you feel lightheaded, rise slowly, and avoid stairs or unsupported walking until you feel steady. Dry mouth may be managed with water, sugar-free gum, or saliva-supporting products when appropriate. Do not treat every effect as acceptable simply because cannabis caused it. A product should improve your chosen arthritis symptom without creating a larger problem. Record the effect, its intensity, when it began, and how long it lasted before deciding whether to continue.

22.2 Signs the dose or product is unsuitable

A product may be unsuitable when it repeatedly interferes with movement, thinking, mood, work, exercise, or medication management. Falls, near falls, worsening confusion, panic, paranoia, agitation, repeated vomiting, or marked loss of motivation indicate that the current plan needs reassessment. Pay attention when the dose keeps increasing, but the function does not improve. Needing more THC for the same relief may reflect tolerance, while continued use despite anxiety, financial strain, missed responsibilities, or poor balance may indicate that the harms now outweigh the benefits. Stop using the product and contact your clinician when unwanted effects are significant, persistent, or difficult to interpret. Bring the label, batch information, THC and CBD amounts, and your dose record. This allows your healthcare team to determine whether a lower dose, different route, different product, or complete discontinuation is appropriate.

22.3 Symptoms needing urgent help

Some symptoms require prompt medical attention rather than waiting for cannabis effects to wear off. Tell the medical team what you used, how much you took, when you took it, and which other medicines or substances were involved. Seek urgent help for:

• Chest pain, severe breathing difficulty, or fainting
• Unresponsiveness or difficulty waking
• A seizure or severe loss of coordination
• Hallucinations accompanied by unsafe behavior
• Thoughts of harming yourself or another person
• Repeated vomiting or inability to keep fluids down
• Severe panic, agitation, or confusion that creates immediate danger
• A hot, swollen joint accompanied by fever or general illness

Do not drive yourself when you may be impaired. Call emergency services or arrange safe transportation depending on the severity of the situation. A painful red joint with fever also requires urgent evaluation because cannabis cannot rule out or treat a joint infection.

23. Movement, Falls, Driving, and Daily Function

23.1 Exercise and physical therapy

Cannabis may make movement feel more comfortable for some patients, but you should also assess whether it changes balance, reaction time, body awareness, coordination, or effort. Reduced pain can help you participate in exercise, yet excessive THC may make your movements less controlled or prevent you from recognizing unsafe strain. Do not use pain suppression to push through sharp pain, sudden weakness, joint instability, or a new loss of movement. These symptoms may signal an injury or mechanical problem that requires assessment. Your exercise goal should be improved function, not simply the ability to ignore discomfort for longer. Track walking distance, range of motion, repetitions, hand function, and recovery after activity. When you work with a physical therapist, discuss cannabis timing openly so the therapist can evaluate whether it improves participation or reduces movement quality. A dose that supports gentle evening exercise may be unsuitable before balance training, aquatic therapy, or strength work.

23.2 Falls and household safety

Arthritis may already affect balance, grip, foot placement, and the ability to rise from a bed, chair, or toilet. Cannabis related dizziness, sleepiness, or slowed reactions can add to these difficulties, especially during the first several doses or after an increase in THC. Review common household risks such as:

• Loose rugs, electrical cords, clutter, and slippery floors
• Pets that move across walking paths
• Poor lighting on the stairs and near the bathroom
• Unsupported transfers from beds, chairs, tubs, and toilets
• Loose footwear or shoes without adequate grip
• Canes, walkers, or crutches that are not adjusted correctly
• Cooking, hot baths, and heating pads used while strongly impaired

Reconsider the dose or product if you experience dizziness, stumbling, or a near fall. Do not assume you will eventually adapt to an unsafe effect. Additional handrails, night lighting, supportive footwear, and a professional mobility assessment may improve safety without requiring you to abandon a potentially useful treatment.

23.3 Driving and safety-sensitive work

Do not drive while cannabis is affecting your attention, coordination, judgment, vision, or reaction time. Feeling relaxed or familiar with THC does not prove that you can respond safely to sudden traffic changes. Arthritis may already slow movement, making added impairment particularly important. The duration of impairment can vary depending on the dose, route, product strength, tolerance, sleep, and other medications. Edibles may continue affecting you longer than expected, and evening use may interfere with driving the following morning. When you are uncertain, arrange another form of transportation. Apply the same caution to machinery, power tools, ladders, workplace vehicles, and powered mobility devices. Workplace drug testing is separate from immediate impairment because THC may remain detectable after noticeable effects have passed. Review local driving laws, employer rules, and professional requirements before beginning treatment, especially when your work involves transportation, construction, healthcare, or public safety.

24. Sleep, Fatigue, Mood, and Quality of Life

24.1 Arthritis-related sleep disruption

Arthritis can disturb sleep by causing pain when you change position, prolonged nighttime aching, or inflammatory discomfort that worsens at rest. You may struggle to fall asleep, wake repeatedly, or rise earlier than intended because a joint becomes stiff or painful. Cannabis may help some patients relax or notice pain less at bedtime, but sedation does not always produce restorative sleep. Track how quickly you fall asleep, how often you wake, total sleep time, morning alertness, and whether you feel able to function the next day. Poor sleep may also involve restless legs, sleep apnea, anxiety, depression, medicines, or an uncomfortable sleep position. Treating every sleep problem with a larger THC dose may leave the underlying cause unrecognized. Discuss loud snoring, breathing pauses, repeated leg discomfort, or severe daytime sleepiness with an appropriate clinician.

24.2 Fatigue and daytime function

Fatigue can come from poor sleep, active inflammation, anemia, thyroid disease, depression, infection, reduced activity, or medication effects. Cannabis may improve nighttime comfort while making daytime tiredness worse, particularly when the dose is high or its effects continue into the morning. Track morning alertness, concentration, physical energy, daytime naps, and participation in work, exercise, or social activities. A product should not be considered successful when you sleep longer but become less active, less motivated, or unable to complete important responsibilities. Persistent fatigue deserves proper evaluation rather than repeated dose increases. Patients with inflammatory arthritis may experience fatigue even when sleep appears adequate. Your clinician may need to review disease activity, laboratory results, mental health, medicines, and other health conditions before deciding that disrupted sleep is the main cause.

24.3 Anxiety, depression, and pain distress

Living with persistent arthritis pain can create worry, frustration, sadness, irritability, and fear of movement. A small cannabis dose may promote short-term relaxation for some patients, but THC can worsen anxiety, panic, paranoia, or emotional instability in others. Track more than your pain score. Notice changes in motivation, social participation, mood, concentration, relationships, and interest in activities you normally enjoy. Feeling emotionally numb or spending more time isolated should not automatically be interpreted as successful coping. Cannabis should not replace proven mental health care or structured pain coping support. Counseling, appropriate medication, support groups, pacing skills, and relaxation practices may address parts of distress that cannabis cannot. Seek urgent help if you develop suicidal thoughts, feel unable to remain safe, or experience severe mood or behavioral changes after using a product.

25. Special Patient Situations

25.1 Older adults

Older adults may need a more cautious cannabis plan because aging can change balance, memory, blood pressure, medication processing, and sensitivity to THC. Arthritis may already make walking, transfers, bathing, and nighttime bathroom trips difficult, so dizziness or confusion can pose a greater risk than for a younger patient. Review your fall history, heart health, vision, hearing, memory, and complete medication list before beginning. Make sure you can read the product label, measure the dose correctly, and remember whether you have already taken it. A family member or trusted support person may help with packaging, droppers, or dose calculations when they are difficult. Monitor your alertness the following morning, not only how you feel shortly after using cannabis. Reassess the dose after an illness, hospital stay, significant weight loss, a new prescription, or a change in kidney or liver function. An amount that was previously manageable may become too strong when your health or medication plan changes.

25.2 Pregnancy, breastfeeding, and fertility

Do not assume that CBD is a safe alternative to THC during pregnancy or breastfeeding. Product labels may be inaccurate; some CBD products contain THC, and dependable research has not established a safe cannabis dose for a developing baby or a breastfed infant. Discuss cannabis before conception with your rheumatologist, obstetric clinician, and pharmacist. Some arthritis medicines also require changes before pregnancy, while others may be continued. Cannabis decisions should not distract from creating a pregnancy-compatible plan that controls inflammation and protects your health. Reproductive discussions should include patients of all genders when fertility, sperm health, pregnancy planning, or medicine exposure may be relevant. The FDA strongly advises against using CBD, THC, or marijuana in any form during pregnancy or while breastfeeding. Do not stop an effective arthritis medicine or replace it with cannabis without a coordinated medical plan.

25.3 Mental health and substance-use history

Tell your clinician about any personal or family history of psychosis, bipolar disorder, severe panic, or serious reactions to cannabis. THC may worsen anxiety, paranoia, agitation, confusion, or unusual thoughts in people who are vulnerable to these effects. Previous cannabis use disorder also matters. Consider whether you have struggled to control cannabis use, needed increasing amounts, continued despite harm, or used it mainly to avoid feeling irritable or unwell. Current high-risk use of alcohol, opioids, sleep medicines, or sedatives can add further concerns involving judgment, breathing, falls, and medication management. This conversation should be supportive rather than judgmental. A history of mental health or substance use problems does not mean your pain should be ignored. It means you may need a lower risk product, closer monitoring, another symptom strategy, or support from a mental health or substance use professional before cannabis is introduced.

26. Surgery, Joint Replacement, and Medical Procedures

26.1 Preparing for surgery

Tell your surgeon and anesthesia team about every cannabis product you use. Include THC and CBD amounts, route, usual dose, frequency, time of your most recent use, and whether you smoke, inhale vapor, swallow edibles, or use concentrated products. Before the procedure, ask:

• When you should stop cannabis
• Whether instructions differ for THC, CBD, smoking, oils, and edibles
• Which arthritis medicines should be continued or temporarily withheld
• How cannabis may affect fasting, anesthesia, nausea, or pain control
• What you should do if stopping cannabis changes sleep, appetite, or pain
• When cannabis may be restarted after the procedure

Do not conceal cannabis use because you fear criticism or cancellation. The anesthesia team needs accurate information to develop an appropriate plan and assess potential concerns related to heart, breathing, sedation, nausea, and pain management. Follow the instructions given for your specific procedure rather than choosing your own stopping period.

26.2 Cannabis after surgery

Do not casually combine cannabis with opioids, sleep medicines, benzodiazepines, muscle relaxants, or other sedating drugs after surgery. These combinations may increase the risk of sleepiness, dizziness, confusion, poor coordination, and falls while you are recovering. Joint replacement patients may already have weakness, swelling, limited movement, and difficulty using crutches or a walker. A cannabis dose that was manageable before surgery may feel stronger when combined with anesthesia effects, reduced food intake, pain medicine, blood loss, or disrupted sleep. Follow wound care, exercise, and rehabilitation instructions even when cannabis reduces discomfort. Do not use pain relief to perform movements that your surgeon or therapist has restricted. Track whether cannabis helps you rest and participate in recovery or causes you to miss exercises, misunderstand instructions, sleep excessively, or move less safely.

26.3 Injections and other procedures

Tell the clinician about cannabis before joint injections, nerve blocks, imaging that requires sedation, dental treatment, or another procedure. Cannabis may influence transportation planning, alertness, anxiety, and how you respond to medicines used for comfort or sedation. Do not arrive intoxicated in an attempt to tolerate a painful or stressful procedure without telling the healthcare team. The clinician needs to know what you have taken before deciding whether the procedure can continue safely. Arrange transportation when sedation or cannabis use makes driving inappropriate. After a joint injection, watch for increasing redness, heat, drainage, fever, severe swelling, or pain that becomes much stronger rather than gradually settling. Do not apply a cannabis cream, balm, or oil over an injection site, open wound, dressing, or incision unless the treating clinician approves it. Cannabis products should remain separate from sterile wound care and infection monitoring.

27. Tolerance, Dependence, and Long-Term Use

27.1 Recognizing tolerance

Tolerance means that the same cannabis dose produces less effect after repeated use. You may notice that relief does not last as long, the original dose no longer supports sleep, or you need more THC to achieve the comfort you previously experienced. Tolerance can develop gradually, making it easy to overlook. You may begin with evening use but slowly add daytime doses, choose stronger products, or use cannabis more frequently without seeing further improvement in movement, sleep, or daily function. An increasing dose is not always the correct response. Stronger arthritis symptoms may reflect a flare, new joint damage, nerve irritation, reduced activity, poor sleep, or another medical change. Review the cause of worsening symptoms before assuming that you simply need more THC. A clinician may recommend adjusting the product, reducing use, taking a planned break, or reviewing your broader arthritis treatment.

27.2 Recognizing problematic use

Cannabis use becomes concerning when it begins interfering with your health, responsibilities, relationships, treatment, or financial stability. The issue is not simply how often you use cannabis. What matters is whether you remain able to control your use and whether it continues to provide more benefit than harm. Possible warning signs include:

• Missing arthritis medicine, medical appointments, exercise, work, or family responsibilities
• Continuing cannabis after falls, panic, confusion, conflict, or financial problems
• Repeatedly using more than you planned
• Trying unsuccessfully to reduce or stop
• Using mainly to prevent irritability, poor sleep, or other withdrawal symptoms
• Losing interest in activities that do not involve cannabis
• Continuing to increase THC even though pain and function remain unchanged

Recognizing these patterns does not mean you have failed. Cannabis affects people differently, and physical dependence can occur with regular use. An honest discussion with your clinician can help you regain control without dismissing your arthritis pain or treating you unfairly.

27.3 Reducing or stopping

Do not assume that every patient can stop frequent or high-dose cannabis without discomfort. A gradual reduction may be easier when you have used THC regularly for a long period. Your clinician can help you reduce the amount, extend the interval between doses, or switch to products that make accurate measurement easier. Temporary symptoms may include irritability, anxiety, reduced appetite, restlessness, vivid dreams, difficulty sleeping, sweating, or a return of pain. These effects do not prove that cannabis remains necessary. They may reflect withdrawal, the original arthritis symptoms, or both. Review other ways to manage pain and sleep while reducing use. Physical therapy, appropriate arthritis medicine, pacing, sleep treatment, counseling, and nonintoxicating symptom options may help. Seek nonjudgmental substance use support when you cannot reduce despite repeated attempts or when cannabis continues causing harm.

28. Legal Access, Cost, Employment, and Travel

28.1 Understanding local access rules

Medical cannabis laws differ according to where you live. Some jurisdictions require patient registration, clinician certification, or a diagnosed qualifying condition. Others allow adult use access but maintain a separate medical program with different product, purchase, possession, tax, or cultivation rules. Authorization in one location may not be recognized elsewhere. Possession limits, product restrictions, home cultivation rules, age requirements, and renewal procedures may also change. A medical cannabis card does not automatically permit use in every public place, rental property, workplace, hospital, or vehicle. Check current government guidance immediately before applying, purchasing, growing, carrying, or using cannabis. Do not rely only on advice from another patient, a dispensary employee, an old website, or rules you remember from a previous year. Legal access refers to what you may obtain or possess, not to whether a product is effective for your arthritis.

28.2 Employment and drug testing

Medical authorization may not prevent workplace consequences. Employer policies, testing programs, disability protections, and accommodation requirements vary by location, occupation, and the type of work you perform. Safety-sensitive roles may involve stricter requirements because impairment could place you or others at risk. THC can remain detectable after the noticeable effects have passed. A positive test may therefore occur when you do not feel intoxicated. Test results also do not always reveal exactly when cannabis was used or whether you were impaired while working. Review your employer’s written drug and medication policies before starting a THC product. Consider speaking with human resources, an occupational health professional, a union representative, or a qualified legal professional when your job may be affected. Do not assume that a clinician’s certification guarantees workplace protection or requires an employer to accept cannabis use.

28.3 Cost, insurance, and travel

Cannabis expenses may include clinician visits, registration or renewal fees, product purchases, transportation, and monitoring appointments. Insurance often does not cover ordinary dispensary products, so you may be responsible for the full cost. Compare products according to the cost of the dose that actually helps, not the package price alone. A cheaper container may become expensive when you need a larger amount, while a concentrated product may cost less per effective dose but increase the risk of measurement mistakes. Include wasted products and ineffective trials when judging affordability. Travel rules require careful review. Carrying cannabis across a border may violate the rules that apply at your destination or during transportation, even when you are authorized at home. Hotels, rental properties, campuses, public housing, cruise lines, and smoke-free buildings may also restrict possession or use. Confirm current requirements before traveling and plan another symptom strategy when cannabis cannot be carried or used legally.

29. Tracking Results and Deciding Whether to Continue

29.1 The arthritis cannabis diary

An arthritis cannabis diary helps you separate a dependable treatment effect from ordinary changes in symptoms. Record your arthritis diagnosis, affected joints, product name, batch, route, THC amount, CBD amount, and exact dose. Include the time you used it, when you first noticed an effect, when the strongest effect occurred, and how long it lasted. Measure pain at rest and during the specific activity you chose as your treatment target. Record the duration of morning stiffness, visible swelling, sleep interruptions, fatigue, mood, concentration, and your ability to complete an important task. Note whether you walked farther, used your hands more comfortably, completed exercise, or slept without as many pain-related awakenings. Include side effects, intoxication, dizziness, anxiety, appetite changes, digestive symptoms, and morning grogginess. Record other medicines, rescue treatments, alcohol, unusual activity, and changes in sleep or stress. These details help you avoid crediting cannabis for an improvement that may have followed an injection, medication change, rest day, or natural symptom fluctuation.

29.2 Continue, adjust, or stop

Continue a cannabis trial only when your predefined symptom or functional goal improves meaningfully, and the result appears repeatedly. The benefit should outweigh the side effects, financial cost, inconvenience, and potential effects on work, driving, exercise, or household safety. An adjustment may be reasonable when you notice some benefit but experience mild, manageable effects. Your clinician may suggest changing the dose, timing, cannabinoid balance, or route. Change one factor at a time so you can identify what improves the result. Stop or seek clinical review when there is no meaningful improvement, intoxication outweighs relief, or you develop falls, anxiety, confusion, medication problems, or worsening function. Reassessment is also appropriate when the dose continually increases or cannabis delays evaluation of swelling, weakness, joint instability, or another change in your arthritis.

29.3 Long-term clinical review

Long-term cannabis use should be reviewed even when the initial trial appears successful. Reassess pain, sleep, movement, daily function, side effects, cost, and dose at planned intervals. Disease activity must be assessed separately, as reduced pain does not confirm that inflammation or structural damage has stopped. Your clinician or pharmacist should periodically review medication interactions, laboratory results, liver health, fall risk, cognition, and signs of tolerance. A supervised dose reduction may help confirm whether cannabis is still providing meaningful benefit or whether continued use has become habitual. Review the plan after surgery, a new diagnosis, a major illness, significant weight change, or the addition of another medicine. Aging, reduced kidney or liver function, and changes in balance can alter how you respond to a previously manageable dose. Continued treatment should remain purposeful, measurable, and safer than the symptoms it is intended to address.

30.1 Essential patient FAQs

These questions address practical situations that patients often encounter after choosing a product, including storage, replacement, disposal, testing, dose accuracy, and communicating cannabis use during unexpected medical care or emergencies. How should I dispose of unused or expired cannabis? Do not flush cannabis or leave it where children or animals can reach it. Follow local disposal guidance, remove identifying labels, and seal unusable products inside undesirable household waste securely. Why can the same cannabis product feel different when I buy it again? Even products with the same name can vary by batch. Compare cannabinoid amounts, ingredients, laboratory results, appearance, smell, and expiration information before assuming your usual dose remains appropriate for you. Can using a THC topical affect a workplace drug test? Yes, repeated use of some THC topicals, especially transdermal products, may contribute to detectable THC. Product formulation matters, so review testing policies before relying on topical use to avoid surprises. What cannabis information should I include in my emergency medical records? List regular cannabis use with your medications in emergency records when possible. Include product type, THC and CBD amounts, usual timing, and your last dose if urgent care occurs unexpectedly. What should I do when my usual product is discontinued? Do not replace it by matching strain names alone. Compare THC, CBD, route, ingredients, dose size, and laboratory testing, then restart cautiously because your response may differ significantly from before. Can I divide a gummy or open a capsule to create a smaller dose? Only split a product when the manufacturer states that cannabinoids are distributed evenly. Cutting an unscored gummy or opening a capsule may produce inaccurate and unpredictable doses for each use. What can I do when hand arthritis makes measuring cannabis difficult? Ask for easy-open packaging, large print labels, measured pumps, or marked syringes when hand pain limits dosing. An occupational therapist can suggest safer tools and adapted techniques for you. Should I transfer cannabis into a container that is easier to open? Keep cannabis in its original labeled container whenever possible. Transferring it can remove dose instructions, batch details, expiration information, and child-resistant features needed for safe identification during everyday use.

30.2 Downloadable worksheets

Patient tools can make your cannabis trial more structured and give your healthcare team clearer information. Useful worksheets include:

• What Type of Arthritis Do I Have summary
• Arthritis symptom and joint map
• Medication and interaction checklist
• Product label decoder
• THC and CBD milligram calculator
• Baseline assessment
• Daily treatment diary
• Continue, adjust, or stop worksheet
• Questions for the rheumatologist
• Surgery and anesthesia disclosure form

Complete your baseline before beginning cannabis and bring the medication checklist to a pharmacist or clinician. Use the daily diary throughout the trial rather than relying on memory at the end. The decision worksheet can help you compare functional improvement, side effects, impairment, and cost before continuing or purchasing another product.

States Where This Condition is Approved for Medical Marijuana

Ohio

Choose DocMJ for Arthritis Cannabis Guidance

At DocMJ, we connect patients with qualified doctors who evaluate eligibility and discuss responsible cannabis use for arthritis symptoms. We help you understand options, goals, and next steps with confidence. Schedule an evaluation today and explore whether cannabis may fit your arthritis care plan.

Citations 

1. Bhaskar, A., Bell, A., Boivin, M., Briques, W., Brown, M., Clarke, H., Cyr, C., Eisenberg, E., Ferreira de Oliveira Silva, R., Frohlich, E., Horsted, T. I., MacCallum, C. A., Müller Vahl, K. R., O’Connell, C., Sealey, R., Seibolt, M., Sihota, A., Smith, B. K., Sulak, D., … Moulin, D. E. (2021). Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: Results of a modified Delphi process. Journal of Cannabis Research, 3, Article 22. https://doi.org/10.1186/s42238-021-00073-1
2. Busse, J. W., Vankrunkelsven, P., Zeng, L., Heen, A. F., Merglen, A., Campbell, F., Granan, L. P., et al. (2021). Medical cannabis or cannabinoids for chronic pain: A clinical practice guideline. BMJ, 374, n2040. https://doi.org/10.1136/bmj.n2040
3. FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello Petersen, R., Guyatt, G., Abeles, A. M., et al. (2020). 2020 American College of Rheumatology guideline for the management of gout. Arthritis & Rheumatology, 72(6), 879–895. https://pubmed.ncbi.nlm.nih.gov/32390306/
4. Heineman, J. T., et al. (2022). A randomized controlled trial of topical cannabidiol for the treatment of thumb basal joint arthritis. The Journal of Hand Surgery, 47(7), 611–620. https://doi.org/10.1016/j.jhsa.2022.03.002
5. Substance Abuse and Mental Health Services Administration. (2023, February). Cannabidiol (CBD): Potential harms, side effects, and unknowns (Publication No. PEP22-06-04-003). National Mental Health and Substance Use Policy Laboratory. https://library.samhsa.gov/sites/default/files/pep22-06-04-003.pdf
6. U.S. Food and Drug Administration. (2023, January 26). FDA concludes that existing regulatory frameworks for foods and supplements are not appropriate for cannabidiol, will work with Congress on a new way forward. U.S. Department of Health and Human Services. https://www.fda.gov/news-events/press-announcements/fda-concludes-existing-regulatory-frameworks-foods-and-supplements-are-not-appropriate-cannabidiol
7. Wang, L., Hong, P. J., May, C., Rehman, Y., Oparin, Y., Hong, C. J., et al. (2021). Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: A systematic review and meta-analysis of randomised clinical trials. BMJ, 374, n1034. https://doi.org/10.1136/bmj.n1034